![]() NEW YORK (GenomeWeb) – Thermo Fisher Scientific's Life Technologies plans to position its Ion Torrent products solely within the clinical market by executing licensing deals, developing its own oncology products, partnering with pharmaceutical companies, and tapping into the various clinical specialties within Thermo Fisher's diagnostics business units, Clinical Sequencing News has learned.Įarlier this month, molecular diagnostics firm VelaDx said it planned to launch clinical next-generation sequencing workflows on the Ion Torrent PGM platform that would include CE-IVD marked oncology and virology assays. Advances in Clinical Genomics Profiling.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |